Syngeneic bone marrow transplantation in combination with PI3K inhibitor reversed hyperglycemia in later-stage streptozotocin-induced diabetes

BACKGROUND: Type 1 diabetes (T1D) is a multiple factor autoimmune disease characterized by T cell-mediated immune destruction of islet β cells. Autologous hematopoietic stem cell transplantation (AHSCT) has been a novel strategy for patients with new-onset T1D, but not for those with a later diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shiyun, Dai, Qianqian, Zhang, Bin, Liu, Siyang, Wang, Ying, Zhang, Yixue, Chen, Dongyue, Zong, Ningning, Wang, Hongwei, Ding, Jingjing, Gao, Qian, Wen, Yanting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667114/
https://www.ncbi.nlm.nih.gov/pubmed/34988151
http://dx.doi.org/10.21037/atm-21-3329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667114/
https://www.ncbi.nlm.nih.gov/pubmed/34988151
http://dx.doi.org/10.21037/atm-21-3329

Ejemplares similares